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HIV-1gP120gP41CD4Chemokine ReceptorAntibody ResponseThe objective of inducing broadly cross-reactiv  neutraliz-
ing antibodies against HIV-1 is promatic because of the
high sequence variability of the viral envelope protins and
the general resistance of primary isolates to neutralizating.
The gP120 glycoprotein elicits both virus-neutralizing and
non-neutralizing antibodies during natural infection.
Non-neutralizing antibodies are often directed against the
gP120 regions that are occlude on the assembled trimer
which are exposed only upon shedding. Neutralizing anti-
bodies must access the functional envelope glycoprotein
complex and typically recognize conserved or variable
epitopes near the receptor-binding regions. HIV envelope
glycoproteins that are conserved among diverseviral
strains are poorly expose to the humoral immune system.
The conserved gP120 surfaces involved in binding to its
three minimally polymorphic ligands, gP41, CD4 and
chemokine receptors, each exhibit particular problems
with respect to the elicitation of or sensitive to neutraliz-
ing antibodies. The moieties involved in gP120-gP41
association are buried in the interior or of the functional
envelope glycoprotein spike. The CD4 binding site is
recessed, flanked by variable regions exhibiting consider-
able glycosylation. The chemokine receptor-binding site is
masked by varial loops-V3 and V2. The relatively con-
served HIV-1 gp120 core has been structurally analyzed,
the outer domain exhibits a variable, heavily glycosylated
surface. This concentrated glycosylation may reduce the
potential of a large portion of the gP120 surface to serve
as an immunogenic target.
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